Physician profile
Becky Wade
NPI 1992869986
$337.59
in general payments reported to CMS, 2019-2025
9 companies · $48.97 in 2025
The $48.97 reported for 2025 was less than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $11.30 · 2021: $120 · 2022: $37.62 · 2023: $89.86 · 2024: $29.97 · 2025: $48.97.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $169.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $168.80 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $81.02 | 2023-2025 | Freestyle Libre 2, Freestyle Libre 3 |
| Boehringer Ingelheim Pharmaceuticals, INC. | $48.86 | 2021-2023 | Jardiance |
| Amgen INC. | $43.05 | 2023 | Repatha, Otezla, Prolia |
| Novo Nordisk INC | $42.37 | 2021 | |
| Merck Sharp & Dohme LLC | $36.93 | 2021 | |
| Astrazeneca Pharmaceuticals LP | $36.34 | 2022-2025 | Airsupra |
| Ascend Therapeutics US, LLC | $24.82 | 2021 | |
| Mayne Pharma Commercial LLC | $12.90 | 2025 | |
| Pfizer INC. | $11.30 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Becky Wade listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.